Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Angelo Armandi
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients With Inflammatory Bowel Diseases
Journal of Clinical Medicine
Related publications
Rapid Response to Vedolizumab Therapy in Biologic-Naïve Patients With Inflammatory Bowel Diseases
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
A Medicoeconomic Review of Early Intervention With Biologic Agents in the Treatment of Inflammatory Bowel Diseases
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
Self-Compassion as a Predictor of Interleukin-6 Response to Acute Psychosocial Stress
Brain, Behavior, and Immunity
Endocrine
Immunology
Behavioral Neuroscience
Autonomic Systems
Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease
Inflammatory Bowel Diseases
Allergy
Immunology
Gastroenterology
Partner Attachment as a Predictor of Long-Term Response to Treatment With Couples Therapy
Journal of Sex and Marital Therapy
Clinical Psychology
Inflammatory Bowel Diseases Activity in Patients Undergoing Pelvic Radiation Therapy
Journal of Gastrointestinal Oncology
Oncology
Gastroenterology
Advances in Nutrition of Patients With Inflammatory Bowel Diseases
Journal of Nutrition & Food Sciences
Physiological Intermolecular Modification Spectroscopy for the Prediction of Response to Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Diseases
Digestive Diseases
Medicine
Gastroenterology
Prm2 - Identification of Dose-Escalation in Biologic Therapy Based on Claims Data: The Example of Patients With Inflammatory Bowel Disease
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
